PS
Paydas, Semra
5 yayın · 27 atıf · 2021–2023
Yayın
5
Atıf
27
Yıllar
2
Yayınlar
| Başlık | Yıl | Tip | Atıf |
|---|---|---|---|
|
Efficacy of Capecitabine and Temozolomide Regimen in Neuroendocrine Tumors: Data From the Turkish Oncology Group
|
2023 | Article | 8 |
|
Comparison of the efficacy and safety of 3 months of CAPOX followed by 3 months of capecitabine and 6 months of CAPOX/FOLFOX in the adjuvant treatment of low-risk stage-III colon cancer treated surgically
|
2023 | Article | 0 |
|
The effect of preferentially expressed antigen in melanoma (PRAME) expression status on survival in stage II and stage III colon cancer
|
2021 | Article | 2 |
|
Efficacy and Safety of Trastuzumab Emtansine in Her2 Positive Metastatic Breast Cancer: Real-World Experience
|
2021 | Article | 9 |
|
The Effect of Inflammatory Markers on Survival in Advanced Biliary Tract Carcinoma Treated with Gemcitabine/Oxaliplatin Regimen
|
2021 | Article | 8 |